• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Relievant Medsystems Inc.

Relievant Medsystems heads for Minnesota after $58m Series E

June 27, 2018 By Brad Perriello

Relievant Medsystems said yesterday that it plans to move to Minnesota now that it’s closed on a $58 million Series E round. Led by Endeavour Vision, joined by new backer RK Mellon and existing investors New Enterprise Assoc., Canaan Ventures, Morgenthaler and Emergent Ventures, the round is earmarked for U.S. commercialization of Relievant’s Intracept intraosseous nerve […]

Filed Under: Funding Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Relievant Medsystems Inc.

Relievant touts 1-year Intracept trial results

February 12, 2018 By Fink Densford

Relievant Medsystems today released the results from the Smart trial of its Intracept intraosseous nerve ablation system exploring its usefulness at treating chronic lower back pain, touting significant decreases in pain from baseline at three months. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical […]

Filed Under: Clinical Trials, Pain Management, Spine Tagged With: Relievant Medsystems Inc.

Relievant Medsystems taps ex-Cameron Health chief Hykes for CEO | Personnel Moves, Sept. 26, 2017

September 26, 2017 By Brad Perriello

Relievant Medsystems said it named former Cameron Medical chief Kevin Hykes to be its new CEO, effective immediately. Hykes, who led Cameron Health to a $1.35 billion buyout in 2012 by Boston Scientific (NYSE:BSX), replaced Alex DiNello, who was named COO, Relievant said. Relievant makes the Intracept device for treating lower back pain. Hykes was most recently […]

Filed Under: Wall Street Beat Tagged With: Breathtec Biomedical Inc, Histogenics, HistoSonics Inc., integer, lombardmedical, Masimo, Medizone, pulmodyne, Relievant Medsystems Inc., RTI Surgical

Relievant Medsystems raises $36m

October 11, 2016 By Fink Densford

Relievant Medsystems said today that it raised a $36 million equity round to support clinical trials for its Intracept intraosseous nerve ablation system. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical procedure to access and ablate the basivertebral nerve. The company touts the system as […]

Filed Under: Funding Roundup, Neuromodulation/Neurostimulation, Orthopedics, Pain Management Tagged With: Relievant Medsystems Inc.

Relievant Medsystems wins FDA clearance for Intracept ablation device for low back pain

July 21, 2016 By Fink Densford

Relievant Medsystems said today it won FDA 510(k) clearance for its Intracept intraosseous nerve ablation system designed for the treatment of chronic lower back pain. The company touted the system as the 1st specific therapy to relieve chronic lower back pain which has persisted for at least 6 months and not responded to conservative care […]

Filed Under: 510(k), Food & Drug Administration (FDA), Pain Management, Regulatory/Compliance Tagged With: Relievant Medsystems Inc.

Relievant lands FDA green light for clinical trial of Intracept back pain therapy

June 3, 2013 By Sony Salzman Leave a Comment

fired/hired

Relievant Medsystems won FDA investigational device exemption for its Intracept back pain therapy, paving the way for the medical device company to continue its SMART pivotal clinical trial.

The Redwood City, Calif.-based company said it will expand the 200-patient randomized, controlled trial to 20 sites across the U.S., where it will evaluate the Intracept therapy in treatment of chronic low back pain.

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Personnel Moves, Relievant Medsystems Inc.

Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat

March 28, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.

Filed Under: News Well, Wall Street Beat Tagged With: Allergan, AngioDynamics, Asahi Kasei Corp., Bio2 Technologies, Bioceptive, BodyMedia, Cardiovascular Systems Inc., Cerner Corp., Cetero, EDAP TMS SA, Edwards Lifesciences, GE Healthcare, Hillrom, Hitachi Medical Systems America, Insulet, Intuitive Surgical, Kips Bay Medical Inc., Layoffs, Luna Innovations Inc., McKesson Corp., Neurometrix, Opko Health Inc., Philips, Relievant Medsystems Inc., Shine Medical Technologies, Smith & Nephew, stjudemedical, Synergetics USA Inc., Tornier Inc., Vuzix, Zoll Medical

Charles River Labs shuffles the deck | Personnel Moves

August 24, 2011 By MassDevice staff Leave a Comment

Charles River Labs

Charles River Laboratories International Inc. (NYSE:CRL)  announced this week that its research models and preclinical services, hand in hand with shuffling its executive deck to drive growth.

Filed Under: News Well Tagged With: Charles River Laboratories International Inc., Corpak Medsystems Inc., Personnel Moves, Relievant Medsystems Inc., Zynex Inc.

Neoprobe presses past controversy, submits Lymphoseek NDA| Regulatory Roundup

August 11, 2011 By MassDevice staff Leave a Comment

Neoprobe

Cancer diagnostics firm Neoprobe Corp. (NYSE Amex:NEOP) pressed past the controversy surrounding its Lymphoseek radiopharmaceutical and submitted a new drug application for FDA review.

The Dublin, Ohio-based company hopes to win clearance for Lymphoseek for use in intraoperative lymphatic mapping, a surgical procedure that identifies and biopsies lymph nodes for traces of cancer.

Filed Under: 510(k), Diagnostics, News Well, Oncology Tagged With: Boston Scientific, BridgePoint Medical Inc., EDAP TMS SA, GE Healthcare, IntraPace Inc., IntriCon Corp., MedShape Solutions Inc., MSMB Capital, Navidea Biopharmaceuticals, Regulatory Roundup, Relievant Medsystems Inc., Toshiba

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS